Patent · US Active

PSMA-binding agents and uses thereof

US11629201B2 · kind B2 · utility

1Cited by

0References

61Claims

0Family size

Assignees

ITM Isotope Technologies Munich SE · DE
Paul Scherrer Institut · CH

Inventors

Martina Benesova · Neckarsteinach, DE
Cristina Magdalena Muller · Nussbaumen, CH
Christoph Umbricht · Baden, CH
Roger Schibli · Baden, CH
Konstantin Zhernosekov · Garching bei München, DE

Key dates

Filing date	May 24, 2018
Grant date	Apr 18, 2023
Priority date	—
Expiry date	Aug 29, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K51/0495
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides novel compounds that are useful as radiopharmaceuticals, imaging agents and for treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.